U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: March 19-25, 2023
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: March 19-25, 2023

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 03/21/2023
Location: Silver Spring, MD
Subject: FDA and Ministry of Food and Drug Safety Collaborations
FDA Participant/Group: JULIA TIERNEY; ANDREA FRISTEDT; SEMA HASHEMI; MARK ABDOO;
Non FDA Participant/Group: Gyuhan Chae, Minsu Jang, Seog Youn Kang, Yoo Mi Kim, Yu-Kyoung Oh (Ministry of Food and Drug Safety);

 

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

Event Date: 03/24/2023
Location: Atlanta, GA
Subject: American Society for Clinical Pharmacology and Therapeutics (ASCPT) Oscar B. Hunter Career Award; Drug Development: Yesterday, Today, Tomorrow
FDA Participant/Group: ISSAM ZINEH;
Non FDA Participant/Group: Industry, academia, clinicians, and other stakeholders

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

Event Date: 03/20/2023
Location: Nashville, TN
Subject: 2023 Society of Toxicology (SOT) Annual Meeting; Speaker: Advancing Single Cell Technologies in Toxicology
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, clinicians, and other stakeholders

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 03/21/2023
Location: Virtual
Subject: Intrepid Alliance Antiviral Summit; Panelist: Advancing Antivirals through Public Sector and Philanthropic Leadership
FDA Participant/Group: N/A
Non FDA Participant/Group: Marco Cavaleri (European Medicines Agency); Tomas Cihlar (Gilead Sciences); Ken Duncan (Bill & Melinda Gates Foundation); Wolfgang Phillips (Health Emergency Preparedness and Response (HERA) European Commission);

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 03/20/2023
Location: Dallas, TX
Subject: Muscular Dystrophy Association Clinical and Scientific Conference - Realizing the Promise of Gene Therapy; Speaker: Keynote Address
FDA Participant/Group: N/A
Non FDA Participant/Group: Research, healthcare, investment, patient, and caregiver stakeholders

Event Date: 03/21/2023
Location: Virtual
Subject: Plenary Day: Discussion of the World Health Organization CGTP (Current Good Tissue Practice) Document
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives of the World Health Organization Expert Committee on Biological Standardization

Event Date: 03/21/2023
Location: Virtual
Subject: University of Florida - Bench to Market Regenerative Medicine Course; Speaker: Regenerative Medicine and Cell-Based Therapies at the Center for Biologics Evaluation and Research
FDA Participant/Group: N/A
Non FDA Participant/Group: Academic stakeholders

Event Date: 03/22/2023
Location: Boston, MA
Subject: Gene Therapy for Rare Disorders Conference; Speaker: Realizing the Promise of Gene Therapy for Rare Diseases
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry stakeholders

Event Date: 03/25/2023
Location: Washington, DC
Subject: National Hemophilia Foundation Workshop; Speaker: FDA Perspective on the Regulatory Future of Novel Technology
FDA Participant/Group: N/A
Non FDA Participant/Group: Research, healthcare, and industry stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 03/21/2023
Location: Virtual
Subject: Interoperability/Business Improvement Districts Act
FDA Participant/Group: SONJA FULMER; KIMBERLEE TRZECIAK; PAUL AGUILAR; BRENDAN O'LEARY; HELENE SHERBURNE; JENNIFER TOMASELLO; TROY TAZBAZ;
Non FDA Participant/Group: Blake Thelander (Rep. Miller-Meeks staff)

Event Date: 03/23/2023
Location: Virtual
Subject: Alliance for a Stronger FDA Webinar: CDRH Medical Device Updates
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of Alliance for a Stronger FDA

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 03/21/2023
Location: Virtual
Subject: Meeting with Science in the Public Interest (CSPI)
FDA Participant/Group: ROBIN MCKINNON;
Non FDA Participant/Group: Peter Lurie (Center for Science in the Public Interest );

Event Date: 03/24/2023
Location: Virtual
Subject: Meeting with Center for Science in the Public Interest (CSPI) Nutrition Announcement
FDA Participant/Group: ROBIN MCKINNON;
Non FDA Participant/Group: Michael Jacobson (Center for Science in the Public Interest (CSPI));

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 03/21/2023
Location: Virtual
Subject: E-cigarette and Cessation
FDA Participant/Group: N/A
Non FDA Participant/Group: Stanton Blantz (University of California San Francisco Center for Tobacco Control Research and Education);

Event Date: 03/22/2023
Location: Virtual
Subject: Webinar Series; Tobacco Regulation and Cessation in an Evolving Landscape
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives from the Smoking Cessation Leadership Center (SCLC)

Event Date: 03/22/2023
Location: Virtual
Subject: Lecture; From Science to Policy: Case Studies from Tobacco Control
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives and students from the Richard M. Fairbanks School of Public Health

Event Date: 03/23/2023
Location: Virtual
Subject: Emerging International Epidemiological Data on Smoke-Free Products
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives from Philip Morris International

Event Date: 03/23/2023
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Senator Richard Blumenthal (D-CT)

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

Event Date: 03/20/2023
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: WILLIAM FLYNN; ROSEMARY EARLEY; CHARLOTTE CONWAY; DAVID EDWARDS; JULIANNA WITTIG; ANTONIA MONIQUE SENNETT; JEANETTE MURPHY; TIMOTHY SCHELL;
Non FDA Participant/Group: Members of the Pet Food Institute (PFI)

Event Date: 03/21/2023
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: WILLIAM FLYNN;
Non FDA Participant/Group: Members of the United States Animal Health Association (USAHA)

Event Date: 03/22/2023
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the Animal Health Institute (AHI)

Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

 

Back to Top